Gut dysbiosis aggravates cognitive deficits, amyloid pathology and lipid metabolism dysregulation in a transgenic mouse model of Alzheimer's disease
Journal of Pharmaceutical Analysis · 2023-12 · 13 (12) · 1526-1547
DOI: 10.1016/j.jpha.2023.07.014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmaceutical Analysis, 2023-12. Verfasst von Chang Qu und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Chinese Medicine, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Chinese University of Hong Kong, National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province.
Themen: Demenz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Chinese Medicine, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
- College of Forestry and Landscape Architecture, South China Agricultural University, Guangzhou, 510640, China.
- Centre for Regenerative Medicine and Health, Hong Kong Institute of Science & Innovation, Chinese Academy of Sciences, Hong Kong Science Park, Shatin, N.T., Hong Kong, China.
- Hong Kong Institute of Integrative Medicine, The Chinese University of Hong Kong, Hong Kong, China.
Förderung
- Chinese University of Hong Kong
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
Zitieren
APA
Qu, C., Xu, Q. Q., Yang, W., Zhong, M., Yuan, Q., Xian, Y. F., & Lin, Z. X. (2023). Gut dysbiosis aggravates cognitive deficits, amyloid pathology and lipid metabolism dysregulation in a transgenic mouse model of Alzheimer's disease. Journal of Pharmaceutical Analysis, 13(12), 1526-1547. https://doi.org/10.1016/j.jpha.2023.07.014
Vancouver
Qu C, Xu QQ, Yang W, Zhong M, Yuan Q, Xian YF, et al. Gut dysbiosis aggravates cognitive deficits, amyloid pathology and lipid metabolism dysregulation in a transgenic mouse model of Alzheimer's disease. Journal of Pharmaceutical Analysis. 2023;13(12):1526-1547. doi:10.1016/j.jpha.2023.07.014
BibTeX
@article{Qu2023,
author = {Qu, Chang and Xu, Qing-Qing and Yang, Wen and Zhong, Mei and Yuan, Qiuju and Xian, Yan-Fang and Lin, Zhi-Xiu},
title = {Gut dysbiosis aggravates cognitive deficits, amyloid pathology and lipid metabolism dysregulation in a transgenic mouse model of Alzheimer's disease},
journal = {Journal of Pharmaceutical Analysis},
year = {2023},
volume = {13},
number = {12},
pages = {1526--1547},
doi = {10.1016/j.jpha.2023.07.014}
}
EUVIMED